What happens if you stop taking Ozempic?

Why do some people stop taking Ozempic?

Ozempic, which contains semaglutide, is a GLP-1 receptor agonist. It was originally developed to treat type 2 diabetes, but it’s also been shown to have a clear effect on appetite regulation and weight management.

Semaglutide is also available under the brand name Wegovy, which is licensed in the UK for weight management. The main difference between Ozempic and Wegovy is the approved use and the dose. The active ingredient is the same, and so is the effect on appetite.

In clinical studies, semaglutide at a dose of 2.4 mg per week, the Wegovy dose, led to an average weight loss of around 15 percent of body weight after just over a year of treatment.

Ozempic is licensed for type 2 diabetes and prescribed at lower doses. Weight loss is often seen, but the average effect is generally smaller than with the higher dose used for obesity.

The effect of semaglutide depends on ongoing treatment and sticking to the dosing plan.

Even though the treatment effect is well documented, stopping GLP-1 medication is quite common in real life, particularly among people using it for weight management without type 2 diabetes. The reasons are often mixed. They can include digestive side effects, cost, supply issues, or expectations about how quickly or how much weight will be lost.

Obesity is a long-term condition. If treatment is seen as something temporary, that can also play a role in stopping. In most cases, stopping isn’t about a lack of motivation. It’s usually a combination of biological and practical factors.

Because semaglutide stays in the body for a while, its effect can continue for several weeks after the last dose. Changes tend to happen gradually rather than overnight.

What happens when weight loss treatment is stopped?

It’s common for weight to gradually increase again after stopping Ozempic. This isn’t because you’ve “failed” or done something wrong. It’s because the biological systems that regulate hunger, fullness and energy balance shift once the medication is no longer there.

Overweight and obesity are chronic conditions. The body actively defends its weight through complex biological mechanisms. When you lose weight, processes are triggered that increase hunger signals, reduce feelings of fullness and make the body more energy efficient.

Ozempic and Wegovy help to quieten hunger and cravings. When treatment stops, those counter-regulatory mechanisms can become more noticeable again, which increases the risk of weight regain.

Stopping treatment is rarely about low motivation. It often reflects uncertainty about side effects, unclear expectations about how long treatment should continue, or a sense that the effect has reduced. In many cases, there may be options such as adjusting the dose, improving follow-up, or adding supportive strategies to improve both tolerance and results. These options are not always known or discussed.

For that reason, a decision to stop GLP-1 treatment should ideally be made in conversation with your doctor, weighing up the risks, likely consequences and possible alternatives.

Appetite and hunger after Ozempic

Many people describe a real sense of “food peace” while taking Ozempic. The constant food noise quietens down. Portions feel naturally smaller. Cravings ease. Fullness comes more quickly.

This happens because semaglutide affects appetite regulation in the brain and slows down stomach emptying.

When the medication is stopped, appetite often shifts gradually. Hunger signals may return and can feel stronger, especially if you’ve become used to feeling full on smaller amounts of food.

Common experiences include:

• More cravings between meals
• Larger portion sizes
• Weaker or delayed feelings of fullness
• More frequent thoughts about food

This isn’t about willpower or discipline. It’s a biological response to the loss of hormonal support from the medication.

Metabolic changes after stopping Ozempic

When semaglutide treatment, whether Ozempic or Wegovy, is stopped, it’s often not just weight that’s affected. Studies show that improvements in blood sugar, HbA1c, waist circumference and blood pressure can lessen once the medication is withdrawn.

For people with type 2 diabetes, blood sugar levels may rise again after stopping. That’s why any change in treatment should always happen in discussion with your doctor.

Current evidence suggests that the effects of Ozempic and Wegovy are largely linked to ongoing treatment. When treatment stops, the body often gradually returns towards previous physiological levels.

Important things to consider before stopping Ozempic

Before deciding to stop semaglutide treatment, whether Ozempic or Wegovy, it’s important to weigh up the potential benefits and possible consequences.

After stopping, many people experience a gradual return of appetite and increased energy intake. This can lead to:

• Partial or significant weight regain
• Return of hunger and cravings
• Worsening of metabolic markers, especially if you’ve had previous metabolic concerns
• Worry or uncertainty about maintaining results

In many situations, adjusting the dose, improving follow-up, or adding lifestyle strategies can improve both tolerance and outcomes. For some people, an individualised maintenance dose may form part of a long-term plan.

Ongoing medical treatment as support

For many people, continuing medication even after reaching a target weight can be medically appropriate. Obesity is a chronic condition, and biological mechanisms continue to influence hunger, fullness and metabolic balance.

Medication can act as biological support, a tool that helps to reduce the body’s counter-signals and make weight stability easier over time.

Research shows that appetite regulation and weight often shift negatively after treatment ends. This supports the view of obesity as a long-term disease rather than a short-term issue. At the same time, there are no clear universal guidelines on how long maintenance treatment should last. The length of treatment needs to be individualised based on medical history, risk profile and response to treatment.

If your weight is stable, a dose adjustment can be discussed with your doctor to find the lowest effective maintenance dose that supports ongoing weight stability and good metabolic control.

How can you maintain weight long term?

The National Weight Control Registry in the United States has followed people who have successfully maintained weight loss over time. Common habits among them include:

• Balanced energy intake
• Regular meals
• Eating breakfast daily
• Choosing filling, nutrient-dense foods
• Weighing regularly
• Keeping a food diary at times
• Daily physical activity

While this research is not UK-specific, these patterns are broadly consistent with what we see in long-term weight maintenance more generally.

Next steps and further information

If you’re considering treatment with Ozempic or Wegovy for weight management, it’s a good idea to understand how the medication works and what to expect. It’s also important to be aware of possible side effects and how to manage them.

A doctor can help you decide whether Wegovy or Ozempic is right for you and advise on how to combine medication with supportive changes to food habits and physical activity.

Medical weight management isn’t a quick fix. It takes time, patience and ongoing support to achieve and maintain a healthier weight.

If you’d like to learn more about medical weight loss treatments and how you can be supported throughout the process, you can read more on our website or speak to a doctor to explore your options and find out whether treatment for obesity is right for you.

Summary

Ozempic and Wegovy are modern medications that affect appetite, hunger and blood sugar regulation. Medication alone isn’t a complete solution for healthy weight loss, but studies show these treatments can deliver meaningful results and provide strong support for improved health.

The effect of treatment is influenced by factors such as food habits, physical activity, motivation and support from healthcare professionals.

When medication is stopped, biological mechanisms often reactivate. Hunger may increase and weight regain can happen gradually. This applies to both Ozempic and Wegovy, as they contain the same active ingredient and work in the same way. The main difference lies in the licensed indication and the dose.

For better long-term health outcomes, Ozempic and Wegovy should be seen as part of a broader weight management plan that includes lifestyle changes. A decision to stop GLP-1 treatment should always be made together with your doctor, considering risks, expected effects and alternative strategies.

Sources

‍NEJM. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Trial).
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

eClinicalMedicine. Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. 2025.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00614-5/fulltext

Diabetes, Obesity and Metabolism. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension.
https://pubmed.ncbi.nlm.nih.gov/35441470/

BMJ. Weight Regain After Cessation of Weight Management Medications: Systematic Review and Meta-Analysis.
https://www.bmj.com/content/392/bmj-2025-085304

American Journal of Clinical Nutrition. Long-term weight loss maintenance. Wing RR, Phelan S. 2005.
https://pubmed.ncbi.nlm.nih.gov/1600282/

‍